美迪西跌2.00%，成交额3137.88万元，主力资金净流出458.48万元

Group 1 - The core viewpoint of the news is that Meidi Xi's stock has experienced fluctuations, with a year-to-date increase of 100.99% but a recent decline in the last five trading days by 8.94% [1] - As of November 19, Meidi Xi's stock price is 60.64 yuan per share, with a market capitalization of 8.147 billion yuan [1] - The company has seen a net outflow of main funds amounting to 458.48 thousand yuan, with significant selling pressure observed [1] Group 2 - Meidi Xi operates in the pharmaceutical and biotechnology sector, specifically in medical services and contract research organization (CRO) services [2] - For the period from January to September 2025, Meidi Xi reported revenue of 843 million yuan, reflecting a year-on-year growth of 5.14%, while the net profit attributable to shareholders was -29.6849 million yuan, showing a significant increase of 76.93% [2] - The number of shareholders increased by 27.83% to 16,500 as of September 30, with an average of 8,149 circulating shares per person, which decreased by 21.96% [2] Group 3 - Since its A-share listing, Meidi Xi has distributed a total of 158 million yuan in dividends, with 33.9365 million yuan paid out in the last three years [3]